V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 280010543 | 280006150 | 1.82 | 91 | null | 2018-04-25 | 2018-04-26 | Bevacizumab 7.5mg/kg | N | Y | 280029318 | DOXORUBICIN + HD MTX |
| 280010544 | 280006151 | 1.8 | 52.4 | Curative (C) | 2013-04-10 | 2014-02-18 | Rituximab | N | N | 280029323 | CYCLOPHOSPHAMIDE + DACTINOMYCIN + VINCRISTINE |
| 280010545 | 280009224 | 0 | 64.2 | Curative (C) | 2016-07-30 | 2016-09-08 | IRINOTECAN + TEMOZOLOMIDE + VINCRISTINE | N | N | 280029327 | CYCLOPHOSPHAMIDE + VINCRISTINE |
| 280010546 | 280009224 | 1.54 | null | null | 2015-10-29 | 2015-11-18 | BLEOMYCIN | 02 | null | 280029327 | CAPE + CARBOPLATIN + CETUXIMAB |
| 280010547 | 280012080 | 1.71 | 91 | Curative (C) | 2015-04-19 | 2015-06-03 | VIDE | null | Y | 280029331 | IRINOTECAN + VINCRISTINE |
| 280010548 | 280006155 | 1.52 | null | Palliative (P) | 2017-02-07 | 2017-02-13 | OCTREOTIDE | N | N | 280029346 | RITUXIMAB |
| 280010549 | 280006157 | 1.81 | null | Palliative (P) | 2017-09-29 | 2017-10-28 | Carboplatin + Cetux + FU (Cycle 1) | N | null | 280029362 | VIDE |
| 280010550 | 280006159 | 1.65 | 93 | Neo-adjuvant (N) | 2016-02-26 | 2016-03-29 | IDELALISIB | 02 | null | 280029366 | CYCLOPHOSPHAMIDE + VINORELBINE |
| 280010551 | 280006159 | 0 | 81.7 | Palliative (P) | 2015-12-08 | 2016-12-02 | ECX | N | N | 280029366 | CARBOPLATIN + CETUXIMAB + FU |
| 280010552 | 280006161 | 1.75 | 67 | Palliative (P) | 2015-03-25 | 2015-04-15 | INTERFERON | 02 | null | 280029380 | CARBOPLATIN + DOCETAXEL + FLUOROURACIL |
| 280010553 | 280006164 | 1.8 | 42.3 | Curative (C) | 2016-07-31 | 2016-08-15 | VIDE | 2 | N | 280029388 | VIDE |
| 280010554 | 280006166 | 1.7 | 0 | Palliative (P) | 2016-03-27 | 2017-06-24 | Capecitabine | 02 | Y | 280029389 | CAPECITABINE + CARBOPLATIN |
| 280010555 | 280010703 | 1.72 | 67.4 | Palliative (P) | 2014-10-20 | 2014-11-09 | BCG Intravesical | N | Y | 280029418 | IMATINIB |
| 280010556 | 280006171 | 1.66 | 91.4 | Curative (C) | 2017-08-10 | 2017-08-31 | VINCRISTINE | N | N | 280029421 | CARBOPLATIN + CETUXIMAB + FLUOROURACIL |
| 280010557 | 280010704 | 1.64 | 51.4 | Palliative (P) | 2014-01-02 | 2014-01-28 | THALIDOMIDE | 02 | N | 280029422 | CETUXIMAB + CISPLATIN + FLUOROURACIL |
| 280010558 | 280006177 | 1.86 | 91.7 | Adjuvant (A) | 2016-02-19 | 2016-03-17 | VIDE | N | N | 280029428 | VINCRISTINE |
| 280010559 | 280006179 | 0 | 83.2 | Palliative (P) | 2015-01-25 | 2015-02-07 | IVADo | N | N | 280029437 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 280010560 | 280006181 | 1.9 | 78.7 | Palliative (P) | 2016-12-09 | 2016-12-12 | Docetaxel | N | N | 280029438 | PEMBROLIZUMAB |
| 280010561 | 280006182 | 1.66 | 80 | Palliative (P) | 2017-04-15 | 2017-04-15 | Cisplatin + Topotecan | 02 | N | 280029438 | DOCETAXEL |
| 280010562 | 280006185 | 1.54 | null | null | 2014-01-30 | 2014-01-30 | Bevacizumab 7.5mg/kg | N | N | 280029448 | CAPECITABINE + OXALIPLATIN |
| 280010563 | 280006189 | 1.58 | 6.2 | Adjuvant (A) | null | 2018-08-01 | FLUOROURACIL + MITOMYCIN | 2 | N | 280029459 | VINCRISTINE |
| 280010564 | 280009241 | 1.85 | 84.8 | Palliative (P) | 2016-09-27 | 2016-09-28 | LANREOTIDE | 2 | N | 280029460 | BENDAMUSTINE + RITUXIMAB |
| 280010565 | 280006194 | 0 | 61.5 | null | null | 2017-08-10 | PEMBROLIZUMAB | 2 | N | 280029471 | VINCRISTINE |
| 280010566 | 280006199 | 0 | null | Disease modification (D) | 2013-09-13 | 2015-06-13 | Ipilimumab | N | null | 280029476 | CREATE TRIAL |
| 280010567 | 280010710 | 1.46 | 51.1 | Curative (C) | 2018-04-15 | 2018-04-15 | CARBOPLATIN + FLUOROURACIL | N | N | 280029488 | MITOMYCIN INTRAVESICULAR |
| 280010568 | 280011767 | 1.67 | null | Neo-adjuvant (N) | 2017-05-16 | 2017-05-21 | BCG Intravesical | null | null | 280029492 | CISPLATIN + VINORELBINE |
| 280010569 | 280006203 | null | 77.05 | Palliative (P) | 2017-04-09 | 2017-04-22 | IPM | 2 | N | 280029494 | METHOTREXATE INTRATHECAL |
| 280010570 | 280006204 | null | 93 | Neo-adjuvant (N) | null | 2018-08-26 | CASPS TRIAL | 02 | null | 280029509 | AXITINIB |
| 280010571 | 280006205 | null | 90 | Curative (C) | 2015-06-20 | 2015-07-25 | DACTINOMYCIN + CYCLO + VINCRISTINE | N | N | 280029512 | BENDAMUSTINE + RITUXIMAB |
| 280010572 | 280009250 | 0 | 78 | Neo-adjuvant (N) | 2016-09-20 | 2016-10-21 | LIPOSOMAL DOXORUBICIN | 02 | N | 280029535 | IMATINIB |
| 280010573 | 280011768 | 1.67 | 58.5 | Disease modification (D) | null | 2013-06-21 | Capecitabine + Cisplatin | 02 | N | 280029539 | IRINOTECAN + TEMOZOLOMIDE + VINCRISTINE |
| 280010574 | 280006209 | 0.62 | 51.3 | Neo-adjuvant (N) | 2017-08-12 | 2017-10-02 | Cyclophosphamide PO +Vinorelbine IV | N | N | 280029548 | CYCLOPHOSPHAMIDE + MTX |
| 280010575 | 280006211 | 1.83 | 83.8 | Neo-adjuvant (N) | 2017-04-09 | 2017-12-05 | VIDE | 02 | N | 280029556 | BEVACIZUMAB + CAPE + OXALIPLATIN |
| 280010576 | 280006216 | 1.72 | 65.5 | Curative (C) | 2014-06-05 | 2014-06-05 | Etoposide oral | N | N | 280029560 | VIDE |
| 280010577 | 280006221 | 1.74 | null | Palliative (P) | 2016-08-08 | 2016-08-08 | Capecitabine | null | null | 280029571 | CARBO + FLUOROURACIL |
| 280010578 | 280011769 | 1.6 | null | Palliative (P) | 2016-05-16 | 2016-05-21 | VIDE | 02 | N | 280029584 | PEMBROLIZUMAB |
| 280010579 | 280009258 | 1.78 | null | Adjuvant (A) | null | 2015-01-23 | DARS Trial | Y | N | 280029589 | CAPECITABINE |
| 280010580 | 280006226 | 1.75 | 90 | Neo-adjuvant (N) | 2010-11-02 | 2015-07-18 | ETOPOSIDE | N | N | 280029599 | NIVOLUMAB |
| 280010581 | 280006228 | 1.74 | 80.8 | Palliative (P) | null | 2018-03-01 | Mitomycin Intravesical | N | Y | 280029608 | DOXORUBICIN + GEMCITABINE |
| 280010582 | 280006229 | 1.74 | 89.2 | Palliative (P) | 2015-11-09 | 2015-11-15 | LIPOSOMAL DOXORUBICIN | null | null | 280029609 | LANREOTIDE |
| 280010583 | 280006231 | 0 | 41.3 | Curative (C) | 2013-05-08 | 2013-06-01 | Vinorelbine (oral) | N | N | 280029620 | CISPLATIN + FLUOROURACIL + RT |
| 280010584 | 280009263 | 1.76 | 104.6 | Palliative (P) | 2015-03-11 | 2015-03-14 | Cyclophosphamide PO +Vinorelbine IV | N | N | 280029628 | AZACITIDINE |
| 280010585 | 280009263 | 1.73 | null | Palliative (P) | 2016-09-04 | 2016-09-04 | Cyclophos + Dex + Lenalidomide | N | N | 280029628 | IVADO |
| 280010586 | 280009265 | 1.8 | 56.8 | Curative (C) | 2018-11-20 | 2018-11-27 | Bevacizumab 7.5mg/kg | N | N | 280029639 | CAPECITABINE + CISPLATIN |
| 280010587 | 280009265 | 1.61 | 61.5 | Palliative (P) | 2018-01-25 | 2018-01-25 | Erlotinib | null | null | 280029639 | CARBOPLATIN + CETUXIMAB |
| 280010588 | 280009266 | 1.78 | 69 | Disease modification (D) | 2017-03-05 | 2017-03-05 | VIDE | null | null | 280029642 | METHOTREXATE HIGH DOSE |
| 280010589 | 280006238 | 1.84 | 56.8 | Curative (C) | 2017-08-17 | 2018-11-20 | INTERFERON | 2 | N | 280029654 | DARS TRIAL |
| 280010590 | 280006242 | null | 70.6 | null | 2017-03-23 | 2018-01-05 | CYCLOPHOSPHAMIDE + DOXORUBICIN + ETOPOSIDE + IFOSFAMIDE + VINCRISTINE | N | N | 280029663 | VIDE |
| 280010591 | 280006246 | null | 85 | null | null | 2013-11-14 | LANREOTIDE | 01 | N | 280029686 | BENDAMUSTINE + RITUXIMAB |
| 280010592 | 280006248 | 0 | 91.7 | Palliative (P) | 2016-07-03 | 2016-07-04 | Cisplatin + Doxorubicin | N | N | 280029690 | GEMCARBO |